Authors:
Valenta, C
Walzer, A
Clausen, AE
Bernkop-Schnurch, A
Citation: C. Valenta et al., Thiolated polymers: Development and evaluation of transdermal delivery systems for progesterone, PHARM RES, 18(2), 2001, pp. 211-216
Authors:
Bernkop-Schnurch, A
Clausen, AE
Hnatyszyn, M
Citation: A. Bernkop-schnurch et al., Thiolated polymers: synthesis and in vitro evaluation of polymer-cysteamine conjugates, INT J PHARM, 226(1-2), 2001, pp. 185-194
Citation: Ae. Clausen et A. Bernkop-schnurch, Direct compressible polymethacrylic acid-starch compositions for site-specific drug delivery, J CONTR REL, 75(1-2), 2001, pp. 93-102
Citation: A. Bernkop-schnurch et al., Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine, J CONTR REL, 71(3), 2001, pp. 277-285
Citation: Ce. Kast et A. Bernkop-schnurch, Thiolated polymers - thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates, BIOMATERIAL, 22(17), 2001, pp. 2345-2352
Authors:
Marschutz, MK
Puttipipatkhachorn, S
Bernkop-Schnurch, A
Citation: Mk. Marschutz et al., Design and in vitro evaluation of a mucoadhesive oral delivery system for a model polypeptide antigen, PHARMAZIE, 56(9), 2001, pp. 724-729
Citation: A. Bernkop-schnurch et al., Thiolation of polycarbophil enhances its inhibition of intestinal brush border membrane bound aminopeptidase N, J PHARM SCI, 90(11), 2001, pp. 1907-1914
Citation: A. Bernkop-schnurch, The use of multifunctional polymers for non-invasive peptide and protein application, EXPERT OP T, 10(9), 2000, pp. 1357-1366
Citation: A. Bernkop-schnurch et S. Steininger, Synthesis and characterisation of mucoadhesive thiolated polymers, INT J PHARM, 194(2), 2000, pp. 239-247
Citation: A. Bernkop-schnurch, Chitosan and its derivatives: potential excipients for peroral peptide delivery systems, INT J PHARM, 194(1), 2000, pp. 1-13
Citation: A. Bernkop-schnurch et B. Gilge, Anionic mucoadhesive polymers as auxiliary agents for the peroral administration of (poly)peptide drugs: Influence of the gastric juice, DRUG DEV IN, 26(2), 2000, pp. 107-113
Authors:
Bernkop-Schnurch, A
Giovanelli, R
Valenta, C
Citation: A. Bernkop-schnurch et al., Peroral administration of enzymes: Strategies to improve the galenic of dosage forms for trypsin and bromelain, DRUG DEV IN, 26(2), 2000, pp. 115-121
Citation: M. Kratzel et A. Bernkop-schnurch, Valaminols, probably the most simplified peptide-analogs acting as pepsin inhibitors, PEPTIDES, 21(2), 2000, pp. 289-293
Citation: Mk. Marschutz et A. Bernkop-schnurch, Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro, BIOMATERIAL, 21(14), 2000, pp. 1499-1507
Citation: A. Bernkop-schnurch et Sc. Thaler, Polycarbophil-cysteine conjugates as platforms for oral polypeptide delivery systems, J PHARM SCI, 89(7), 2000, pp. 901-909
Citation: Ae. Clausen et A. Bernkop-schnurch, In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil, J PHARM SCI, 89(10), 2000, pp. 1253-1261
Citation: A. Bernkop-schnurch, Polymer/inhibitor conjugates - A promising strategy to overcome the enzymatic barrier to perorally administered (poly)peptide drugs?, STP PHARM S, 9(1), 1999, pp. 83-92
Authors:
Bernkop-Schnurch, A
Kirchmayer, R
Kratzel, M
Citation: A. Bernkop-schnurch et al., Synthesis, development and in vitro evaluation of drug delivery systems with protective effect against degradation by pepsin, J DRUG TAR, 7(1), 1999, pp. 55-63
Citation: A. Bernkop-schnurch et J. Freudl, Comparative in vitro study of different chitosan-complexing agent conjugates, PHARMAZIE, 54(5), 1999, pp. 369-371